Full Text
EE448 Evaluation of the Societal Impact of Emicizumab in France Since Its Market Authorization: Budget Impact From 2018 to 2024

Abstract

Authors

Henri Leleu Laurie Fraticelli Gwladys Touvron Roula Ajjouri Valérie Chamouard

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×